Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Product type
Topic
- (-) Shortages and supply disruptions (16)
- Safety monitoring and information (127)
- Compliance and enforcement (33)
- Import and export (31)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
31 result(s) found, displaying 1 to 25
-
Medicine shortage alertsInformation and approvals to manage Presolol 200 tablet shortage
-
Medicine shortage alertsSerious Scarcity Substitution Instrument extended due to continued shortages of HRT patch products.
-
Medicine shortage alertsWe have made a Serious Scarcity Substitution Instrument (SSSI) that starts on 22 December 2025 and ends on 28 April 2026. The SSSI allows a pharmacist to dispense an equivalent quantity of clonidine 100 mcg tablets, if appropriate, without a new prescription
-
Medicine shortage alertsPharmaceutical companies Novo Nordisk and Eli Lilly are discontinuing some of their insulin products.
-
Medicine shortage alertsPharmacists can substitute 10 mg simvastatin tablets during the shortage of the 5 mg tablets.
-
Medicine shortage alertsPharmacists can substitute whichever brand and strength of nicorandil is available during the shortage.
-
Medicine shortage alertsPharmacists can dispense 200 mg tablets during the shortage.
-
Medicine shortage alertsConcerta modified-release tablets will remain in shortage at various times until the end of 2026
-
Medicine shortage alertsWe have approved overseas-registered substitutes for Pegasys 135 micrograms/0.5 mL and 180 micrograms/0.5 mL pre-filled syringes.
-
Medicine shortage alertsVarious brands of metformin hydrochloride 1000 mg immediate-release tablets are in shortage.
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Market actionsTakeda Pharmaceuticals Australia has issued a product alert for Vyvanse capsules due to minor packaging errors. The medication is safe to use as prescribed.
-
Medicine shortage alertsPharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
-
Safety alertsGold Max Blue capsules pose a serious risk to your health and should not be taken.
-
Safety alertsMAXMAN tablets pose a serious risk to your health and should not be taken.
-
Safety alertsAfrican Vigorous Max Strength poses a serious risk to your health and should not be taken.
-
Safety alertsWe have tested a further 6 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989.
-
Safety alertsZiyinzhuangyang tablets pose a serious risk to your health and should not be taken.
-
Safety alertsDark Horse Capsules pose a serious risk to your health and should not be taken.
-
Safety alertsBullblood tablets pose a serious risk to your health and should not be taken.
-
Safety alertsExcite for her tablets pose a serious risk to your health and should not be taken.
-
Safety alertsKamasutra herbal jelly for him bottle poses a serious risk to your health and should not be taken.
-
Safety alertsTantra Jelly oral jelly satchels pose a serious risk to your health and should not be taken.
-
Safety alertsKamasutra Herbal Jelly for him oral jelly sachets pose a serious risk to your health and should not be taken.
-
Safety alertsThrob Herbal supplement tablets pose a serious risk to your health and should not be taken.